FEMY CIK: 1339005

Femasys Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
25.6
FY22:
14.1
FY23:
23.2
FY24:
8.02
FY25:
16.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.95
FY22:
2.76
FY23:
4.58
FY24:
4.42
FY25:
4.27
Total assets
Change from FY21 to FY25
millions USD
FY21:
28.6
FY22:
16.9
FY23:
27.8
FY24:
12.4
FY25:
20.7

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
1.69
FY22:
1.53
FY23:
3.05
FY24:
8.58
FY25:
3.64
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.55
FY22:
0.13
FY23:
6.35
FY24:
1.56
FY25:
11.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
26.3
FY22:
15.2
FY23:
18.4
FY24:
2.30
FY25:
5.87
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
28.6
FY22:
16.9
FY23:
27.8
FY24:
12.4
FY25:
20.7

All amounts in millions USD Data source:SEC EDGAR